BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9004095)

  • 1. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence.
    Whelton PK; Perneger TV; He J; Klag MJ
    J Hum Hypertens; 1996 Oct; 10(10):683-9. PubMed ID: 9004095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and risk of cardiovascular disease in Chinese men and women.
    Gu D; Kelly TN; Wu X; Chen J; Duan X; Huang JF; Chen JC; Whelton PK; He J
    Am J Hypertens; 2008 Mar; 21(3):265-72. PubMed ID: 18188156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; Castañeda O; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodialysis-unresponsive blood pressure: cardiovascular mortality predictor?
    Mourad A; Khoshdel A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrology (Carlton); 2005 Oct; 10(5):438-41. PubMed ID: 16221091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing population blood pressure: 15 years of follow-up in the Copenhagen City Heart Study (CCHS).
    Andersen UO; Jensen G
    Blood Press; 2004; 13(3):176-82. PubMed ID: 15223727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
    Weir MR
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):100S-105S. PubMed ID: 15837552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease.
    Dzielińska Z; Prejbisz A; Makowiecka-Cieśla M; Januszewicz A; Tyczyński P; Demkow M; Zieliński T; Kadziela J; Florczak E; Ruzyłło W
    Blood Press Monit; 2009 Jun; 14(3):99-102. PubMed ID: 19417635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs.
    Börgel J; Sanner BM; Keskin F; Bittlinsky A; Bartels NK; Büchner N; Huesing A; Rump LC; Mügge A
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1081-7. PubMed ID: 15607612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
    Saelen MG; Prøsch LK; Gudmundsdottir H; Dyrbekk D; Helge Hunderi O; Arnesen E; Paulsen D; Skjønsberg H; Os I
    Blood Press; 2005; 14(3):170-6. PubMed ID: 16036497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model of risk: implications of increasing pulse pressure and systolic blood pressure on cardiovascular disease.
    Alderman MH
    J Hypertens Suppl; 1999 Dec; 17(5):S25-8. PubMed ID: 10706322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
    Abderrahim E; Zouaghi K; Kheder A; Cherif M; Boubaker K; Mahfoudhi M; Hedri H; Ounissi M; Ben Hamida F; Ben Moussa F; Ben Abdallah T; El Younsi F; Kâaroud H; Béji S; Goucha R; Ben Maïz H
    Transplant Proc; 2004; 36(6):1820-3. PubMed ID: 15350486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control among Indians with hypertension: the I-Target survey.
    Hathial M
    J Indian Med Assoc; 2007 Jul; 105(7):401-2, 404, 410. PubMed ID: 18178998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.